Cti Biopharma reported $-23381000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Applied Genetic Technologies AGTC:US $ -16003000 2.62M
Baxter International BAX:US $ 616M 140M
Bristol Myers Squibb BMY:US $ 2985M 18M
Cti Biopharma CTIC:US $ -23381000 3.88M
Cytori Therapeutics CYTX:US $ -3481000 906K
Eli Lilly And LLY:US $ 2055.2M 626.8M
Geron GERN:US $ -25674000 3.22M
Mirati Therapeutics MRTX:US $ -79499000 84.69M
Northwest Biotherapeutics NWBO:US -10049000 2.36M
Novartis NVS:US 3.48B 77M
Novartis NOVN:VX 3.48B 77M
Seattle Genetics SGEN:US $ -297963000 208.36M
Sunesis Pharmaceuticals SNSS:US $ -10799000 1.48M
Teva Pharmaceutical Industries TEVA:US 806M 23M
YTE INCY:US $ 247.47M 92.16M